ArticleInternational journal of pharmaceutics: X2026

Tumor-responsive PEGylated mesoporous nanoparticles achieve enhanced chemotherapy and reduced toxicity in prostate cancer.

Yangyang Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.